SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017867
Filing Date
2023-11-07
Accepted
2023-11-07 07:52:53
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20230930x10q.htm   iXBRL 10-Q 2124615
2 EX-10.1 qure-20230930xex10d1.htm EX-10.1 125851
3 EX-31.1 qure-20230930xex31d1.htm EX-31.1 15055
4 EX-31.2 qure-20230930xex31d2.htm EX-31.2 15064
5 EX-32.1 qure-20230930xex32d1.htm EX-32.1 14754
6 GRAPHIC qure-20230930xex10d1001.jpg GRAPHIC 5696
  Complete submission text file 0001558370-23-017867.txt   7734574

Data Files

Seq Description Document Type Size
7 EX-101.SCH qure-20230930.xsd EX-101.SCH 43117
8 EX-101.CAL qure-20230930_cal.xml EX-101.CAL 50921
9 EX-101.DEF qure-20230930_def.xml EX-101.DEF 232994
10 EX-101.LAB qure-20230930_lab.xml EX-101.LAB 435170
11 EX-101.PRE qure-20230930_pre.xml EX-101.PRE 343577
58 EXTRACTED XBRL INSTANCE DOCUMENT qure-20230930x10q_htm.xml XML 1209755
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 231381624
SIC: 2834 Pharmaceutical Preparations